Swati Mehrotra, MD Gynecologic Cytopathology Questions

Size: px
Start display at page:

Download "Swati Mehrotra, MD Gynecologic Cytopathology Questions"

Transcription

1 Swati Mehrotra, MD Gynecologic Cytopathology Questions Question #1 A liquid based pap smear is considered to have adequate cellularity according to Bethesda 2001 if a. It has 6000 squamous cells and no detectable endocervical cells b. It has over 8000 squamous cells with over 75% obscured by inflammation c. It has 2000 well visualized squamous cells and five groups of endocervical cells with each group having more than 10 endocervical cells d. It has only endocervical cells and blood Question #2 The following specimen is unsatisfactory for evaluation a. A LBP with 8000 cells of which 25% cells are obscured by inflammation b. A LBP with 2000 cells and changes suggestive of herpes simplex virus c. A LBP with 2000 cells and changes suggestive of LGSIL d. A conventional smear with cells and no endocervical cells Question #3 The following is required as per Bethesda 2001 a. Report benign endometrial cells in a woman who is 45 years old b. Report benign endometrial cells in a women who is 45 years old only if she is in her second half of menstrual cycle c. Report benign endometrial cells in a 26 year old if in the second half of menstrual cycle d. Report benign appearing endometrial cells only in post menopausal women

2 Question #4 A technical supervisor of the cytopathology laboratory should be a. Certified by the American Society of Clinical Pathology b. Can be a clinical pathologist and laboratory director c. Should be an anatomic pathologist d. Should be a cytotechnologist with 3 years of full time experience in the last 10 years Question #5 Slides, requisitions and reports in a cytology laboratory should be retained for a. 10, 2, 10 years b. 2, 5, 5 years c. 5, 2, 10 years d. Indefinitely, 2, 5 years Question # 6 Watery diathesis is commonly seen in a. Endocervical adenocarcinoma b. Squamous cell carcinoma c. Extra uterine adenocarcinomas d. Endometrial adenocarcinomas Question #7 Neuroendocrine cervical carcinomas are most commonly associated with a. HPV 16

3 b. HPV 18 c. HPV 45 d. HPV 31 Question #8 Which of the following is the most widely used surrogate marker of HPV? a. Ki67 b. Cyclin E c. P16 INK4a d. Antibodies to MCM2 and TOP2a Question#9 As per the ASCCP guidelines women over 30 years of age a. Should have an annual pap smear b. Should have a pap smear every three years if three consecutive cytologies have been negative c. Should have a HRHPV test annually and a pap every three years d. Do not need to have a pap test as very little chance of getting dysplasia Question #10 HPV Viral Oncogenes most important for neoplastic transformation of cells are a. Viral capsid protein L1 b. Viral oncogenes E6 and E7 c. Oncogenes p53 and Rb d. Viral oncogene E1 and E4

4 Question #11 An 18 year old with HSIL on pap and positive HRHPV should be triaged by as per ASCCP guidelines a. Immediate LEEP b. Colposcopy c. Both d. None Question #12 A 28 year old post partum woman would be expected to have a maturation index of B. 10:30:70 C. 60:20:20 D. 80:20:0 Question #13 Choose the correct scenario a. The bivalent HPV vaccine is required to be administered to all males 9 to 26 years of age b. The quadrivalent HPV vaccine is recommended for all females aged 9 to 26 years provided they are still virgins c. The quadrivalent HPV vaccine is recommended for all females aged 9 to 26 years provided their prevaccine HPV test is negative d. The quadrivalent HPV vaccine is recommended for all females aged 9 to 26 years regardless of their sexual history, however the efficacy is highest in women with no history of prior sexual activity

5 Question #14 The best diagnosis for the following findings on a Pap smear from a 27 y/o woman as per the Bethesda Lexicon is (Cytologic findings: >10 mature squamous cells/ 40x field average Five endocervical / metaplastic cell identified Endometrial cells present Scattered clue cells seen) a. Satisfactory for evaluation, transformation zone component present, Negative for intraepithelial lesion or malignancy b. Unsatisfactory for evaluation due to lack of transformation zone c. Satisfactory for evaluation, transformation zone component not identified, Negative for intraepithelial lesion or malignancy d. Satisfactory for evaluation, transformation zone component not identified, Negative for intraepithelial lesion or malignancy and endometrial cells present e. Question #15 Which of the following statements are true except a. HPV is a sexually transmitted disease b. Women 15 to 21 have a high incidence of HPV infection c. Women 15 to 21 should be aggressively triaged for HPV infections and dysplasia d. The risk of invasive cervical cancer in women 15 to 21 is 1 2/ 1000,000/ year

6 e. The American College of Obstetrics and Gynecology (ACOG) recommends initiation of screening for cervical cancer at 21 years of age.

7 ANSWERS GYN Cytopathology Swati Mehrotra, MD 1. A 2. B 3. A 4. C 5. C 6. D 7. B 8. C 9. B 10. B 11. B 12. D 13. D 14. C 15. C

Explanation of your PAP smear

Explanation of your PAP smear Explanation of your PAP smear Approximately 5-10% of PAP smears in the United States are judged to be abnormal. Too often, the woman who receives this news worries that she already has, or will develop,

More information

Management of Abnormal PAP Smears. K Chacko, MD, FACP 2010 GIM Conference

Management of Abnormal PAP Smears. K Chacko, MD, FACP 2010 GIM Conference Management of Abnormal PAP Smears K Chacko, MD, FACP 2010 GIM Conference Scope of the Problem About 7-10% 7 of PAPs will come back abnormal 3.5 to 4 million in the US each year Approximate 4000 deaths

More information

Pap smears, cytology and CCHC lab work and follow up

Pap smears, cytology and CCHC lab work and follow up Pap smears, cytology and CCHC lab work and follow up What is a Pap Smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the

More information

Cervical Cancer Screening and Management Guidelines: Changing Again, Huh?

Cervical Cancer Screening and Management Guidelines: Changing Again, Huh? Cervical Cancer Screening and Management Guidelines: Changing Again, Huh? Summary of 2013 recommendations from ASC (American Cancer Society), ASCCP (American Society for Colposcopy and Cervical Pathology),

More information

American Academy of Family Physicians

American Academy of Family Physicians American Academy of Family Physicians Barbara E. Stanford MD Grand Rapids Family Medicine Residency Wege Family Medicine HPV is transient in most women HPV-75% Normal ASCUS LSIL HSIL Cancer 80-90% 75%???

More information

Cervical Cancer The Importance of Cervical Screening and Vaccination

Cervical Cancer The Importance of Cervical Screening and Vaccination Cervical Cancer The Importance of Cervical Screening and Vaccination Cancer Cells Cancer begins in cells, the building blocks that make up tissues. Tissues make up the organs of the body. Sometimes, this

More information

Management of Abnormal Pap Smear Clinical Practice Guideline

Management of Abnormal Pap Smear Clinical Practice Guideline Management of Abnormal Pap Smear Clinical Guideline General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method

More information

NATIONAL GUIDELINE FOR CERVICAL CANCER SCREENING PROGRAMME

NATIONAL GUIDELINE FOR CERVICAL CANCER SCREENING PROGRAMME NATIONAL GUIDELINE FOR CERVICAL CANCER SCREENING PROGRAMME CERVICAL CANCER Introduction Cancer of the cervix is the second most common form of cancer amongst South African women. Approximately one in every

More information

PROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL ABNORMAL PAP SMEAR (ABNORMAL CERVICAL CYTOLOGIC FINDINGS) Kathleen Dor

PROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL ABNORMAL PAP SMEAR (ABNORMAL CERVICAL CYTOLOGIC FINDINGS) Kathleen Dor 1 ABNORMAL PAP SMEAR (ABNORMAL CERVICAL CYTOLOGIC FINDINGS) Kathleen Dor Cervical cytology screening has significantly decreased rates of mortality from cervical cancer; however, 400 women die each year

More information

Abnormal Pap Smear Tracking in General Internal Medicine Clinic

Abnormal Pap Smear Tracking in General Internal Medicine Clinic Abnormal Pap Smear Tracking in General Internal Medicine Clinic J A C O B K U R L A N D E R & T A R A O B R I E N C A R Q I P R O J E C T J A N U A R Y 2 0, 2 0 1 0 PDSA cycle Plan Act Do Study Our Charge

More information

The Cervical Screening Manual

The Cervical Screening Manual The Cervical Screening Manual A Guide for Health Departments and Providers Collaboration Partners: Chronic Disease and Injury Section Breast and Cervical Cancer Control Program Women s and Children s Health

More information

Screening for Cancer of the Cervix

Screening for Cancer of the Cervix Screening for Cancer of the Cervix An Office Manual for Health Professionals Cervical Cancer Screening Program tenth Edition 2013 Contact Information Cervical Cancer Screening Program (CCSP) Administration

More information

Cervical Cancer Screening Guideline

Cervical Cancer Screening Guideline Cervical Cancer Screening Guideline Prevention 2 Abbreviations Used 2 Specimen Collection Techniques 3 Screening 4 Management Women 21 Years and Older Pap results 5 findings: ASC-US and LSIL 6 findings:

More information

Examples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.

Examples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening. CANCER SCREENING Dr. Tracy Sexton (updated July 2010) What is screening? Screening is the identification of asymptomatic disease or risk factors by history taking, physical examination, laboratory tests

More information

Cancer of the Cervix

Cancer of the Cervix Cancer of the Cervix WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 A woman's cervix (the opening of the uterus) is lined with cells. Cancer of the cervix occurs when those cells change,

More information

XI International Workshop of Lower Genital Tract Pathology HPV Disease: The global battle Rome 19-21 April 2012

XI International Workshop of Lower Genital Tract Pathology HPV Disease: The global battle Rome 19-21 April 2012 XI International Workshop of Lower Genital Tract Pathology HPV Disease: The global battle Rome 19-21 April 2012 Thursday 19 nd April 2012 Morning Sessions 07.50-08.20 Registration 08.20-08.40 Welcome:

More information

GUIDELINE DOCUMENT CERVICAL CANCER SCREENING IN SOUTH AFRICA 2015

GUIDELINE DOCUMENT CERVICAL CANCER SCREENING IN SOUTH AFRICA 2015 GUIDELINE DOCUMENT CERVICAL CANCER SCREENING IN SOUTH AFRICA 2015 Cervical cancer remains an important cause of morbidity and mortality in South Africa. At present the national cervical cancer prevention

More information

Cervical Cancer Screening

Cervical Cancer Screening Clinical in Oncology Cervical Cancer Screening V.1.2009 Continue www.nccn.org Panel Members * Edward E. Partridge, MD/Chair University of Alabama at Birmingham Comprehensive Cancer Center Nadeem Abu-Rustum,

More information

GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET

GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET When detected, HPV infection is easily managed and rarely proceeds to cancer Very few women with HPV develop cervical cancer HPV infections are only one of

More information

Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University

Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University Burden of HPV related cancers l l Cervical Cancer of the cervix

More information

The society for lower genital tract disorders since 1964.

The society for lower genital tract disorders since 1964. The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology

More information

Cervical Cancer Screening. Clinical Practice Guidelines for Average Risk Women

Cervical Cancer Screening. Clinical Practice Guidelines for Average Risk Women QEYGYN051 Cervical Cancer Screening Clinical Practice Guidelines for Average Risk Women For Approval of the Provincial Medical Affairs Committee October 2013 Table of Contents Page Background Information

More information

Sage Screening Program. Provider Manual

Sage Screening Program. Provider Manual Sage Screening Program Provider Manual Sage Screening Program Minnesota Department of Health 85 E. 7th Place, Suite 400 P.O. Box 64882 St. Paul, Minnesota 55164-0882 (651) 201-5600 (phone) (651) 201-5601-

More information

How HPV drives new cervical cancer screening guidelines

How HPV drives new cervical cancer screening guidelines How HPV drives new cervical cancer screening guidelines L. Stewart Massad, M.D. Dept. of Obstetrics & Gynecology Washington University School of Medicine St. Louis, MO Disclosure I do not have financial

More information

Cervical Cancer Prevention and Early Detection What is cervical cancer?

Cervical Cancer Prevention and Early Detection What is cervical cancer? Cervical Cancer Prevention and Early Detection What is cervical cancer? Cervical cancer starts in cells lining the cervix. The cervix is the lower part of the uterus (womb). It is sometimes called the

More information

SCREENING FOR CANCER OF THE CERVIX

SCREENING FOR CANCER OF THE CERVIX SCREENING FOR CANCER OF THE CERVIX An Office Manual for Health Professionals This manual has been prepared by the Cervical Cancer Screening Program of the BC Cancer Agency to support effective use of the

More information

ALABAMA BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM PROVIDER MANUAL

ALABAMA BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM PROVIDER MANUAL ALABAMA BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM PROVIDER MANUAL Revised January 2012 1 TABLE OF CONTENTS PROGRAM OVERVIEW.. 3 INTRODUCTION 5 SCREENING ELIGIBILITY GUIDELINES 6 PATIENT RIGHTS..

More information

HUMAN PAPILLOMAVIRUS (HPV) FACT SHEET

HUMAN PAPILLOMAVIRUS (HPV) FACT SHEET HUMAN PAPILLOMAVIRUS (HPV) FACT SHEET Background Information - Human Papillomavirus HPV is the name of a group of viruses that include more than 80 different types associated with a variety of epidermal

More information

Understanding. Cervical Changes A Health Guide for Women. National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Understanding. Cervical Changes A Health Guide for Women. National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Cancer Institute Understanding Cervical Changes A Health Guide for Women U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health This guide helped me talk with my doctor after

More information

The link between cervical cancer and HPV (human papillomavirus)

The link between cervical cancer and HPV (human papillomavirus) The link between cervical cancer and HPV (human papillomavirus) The link between cervical cancer and HPV Key facts: HPV is a virus (the human papillomavirus). Almost all abnormal Pap smear results are

More information

Accent on Health Obgyn, PC HPV Frequently Asked Questions

Accent on Health Obgyn, PC HPV Frequently Asked Questions 1. What is HPV? 2. How do you get HPV? 3. How common is HPV? 4. What are the symptoms of HPV? 5. Can HPV be treated? 6. What is the HPV test and how is it different from a PAP test? 7. Can the HPV test

More information

Liquid-based cytology

Liquid-based cytology Liquid-based cytology Claire Bourgain UZBrussel Introduction LBC for gynaecological cytology has been introduced in Belgium a decade ago There is no consensus On performance compared to conventional cytology

More information

Provider Reimbursement for Women's Cancer Screening Program

Provider Reimbursement for Women's Cancer Screening Program Reimbursement Schedule July 1, 2015 June 30, 2016 Office Visits - Established Patients Office Visit / Minimal / no physician 99211 $ 16.70 Office Visit / Problem focused History / exam 99212 $ 36.46 Preventive

More information

worry When to Cervical Abnormalities CME Workshop What s the situation? What are the trends? By Dianne Miller, MD, FRCSC In this article:

worry When to Cervical Abnormalities CME Workshop What s the situation? What are the trends? By Dianne Miller, MD, FRCSC In this article: CME Workshop When to worry Cervical Abnormalities By Dianne Miller, MD, FRCSC What s the situation? Over 600,000 Papanicolaou s (Pap) smears were performed in British Columbia in 2000. Approximately 13,400

More information

Genital Human Papillomavirus. Patti E. Gravitt, PhD Johns Hopkins University

Genital Human Papillomavirus. Patti E. Gravitt, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Medicaid Family Planning Waiver Services CPT Codes and ICD-9 Diagnosis Codes

Medicaid Family Planning Waiver Services CPT Codes and ICD-9 Diagnosis Codes Family Planning Waiver Services CPT Codes and ICD-9 Diagnosis Codes CPT Code Description of Covered Codes Evaluation and Management 99384FP 99385FP 99386FP 99394FP 99395FP 99396FP 99401FP 99402FP 99403FP

More information

HPV and the Future of Cervical Screening

HPV and the Future of Cervical Screening HPV and the Future of Cervical Screening John Tidy, Professor of Gynaecological Oncology Chair, National Colposcopy QA Committee, Sheffield What is HPV? Small ds DNA virus Over 140 genotypes described

More information

Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014

Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014 Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014 1 Background l Selected types of HPV cause cervical cancer, anogenital warts, and other anogenital and

More information

The Pap Smear: Guidelines for Screening and Follow-up

The Pap Smear: Guidelines for Screening and Follow-up The Pap Smear: Guidelines for Screening and Follow-up The incidence of and mortality from cervical cancers have decreased with the Pap smear's opportunistic use in Canada. The rate of decline has eased,

More information

CXCA-MSP. The next step in cervical cancer prevention! GynTect : Epigenetic biomarkers for reliable cancer diagnostics. www.gbo.

CXCA-MSP. The next step in cervical cancer prevention! GynTect : Epigenetic biomarkers for reliable cancer diagnostics. www.gbo. CXCA-MSP The next step in cervical cancer prevention! GynTect : Epigenetic biomarkers for reliable cancer diagnostics www.gbo.com/diagnostics H 3 C NH 2 NH H 3 C 2 N mc N mc N H N O H O The challenge of

More information

HPV, Cervical Dysplasia and Cancer

HPV, Cervical Dysplasia and Cancer FACTSHEET HPV, Cervical Dysplasia and Cancer Summary Cervical dysplasia is an abnormal change in the cells of the cervix in the uterus. Early changes, called low-grade lesions by doctors, may persist and

More information

Medicaid Family Planning Waiver Services CPT Codes and ICD-10 Diagnosis Codes

Medicaid Family Planning Waiver Services CPT Codes and ICD-10 Diagnosis Codes CPT Code Description of Covered Codes Evaluation and Management 99384FP 99385FP Family planning new visit 99386FP 99394FP 99395FP Family planning established visit 99396FP 99401FP HIV counseling (pre-test)

More information

Making Sense of Your Pap and HPV Test Results

Making Sense of Your Pap and HPV Test Results Making Sense of Your Pap and HPV Test Results Keep this booklet until you get your test results back from your doctor. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention

More information

THE CYTOLOGY LABORATORY

THE CYTOLOGY LABORATORY THE CYTOLOGY LABORATORY OF PATHOLOGY CASE WESTERN RESERVE UNIVERSITY AND UNIVERSITY HOSPITALS CLEVELAND, OHIO 48 THE INSTITUTE I I Motifs from medieval guilds, zodiac signs of Libra and Cancer, the urine

More information

Creation Date: 12/24/2008. Effective Date: 07/14/2009 Date of Revision/Review: 07/14/2009 Version #:1 Date of Next Review: 07/14/2010

Creation Date: 12/24/2008. Effective Date: 07/14/2009 Date of Revision/Review: 07/14/2009 Version #:1 Date of Next Review: 07/14/2010 Site: Fremont Rideout Health Group Laboratory Services Policy and Procedure Creation Date: 12/24/2008 Subject/Title: Collection of Specimens for Conventional & ThinPrep Pap Tests, HPV Document Owner: Rogers,

More information

FRIEND TO FRIEND CPT CODES 2015 2016. Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure)

FRIEND TO FRIEND CPT CODES 2015 2016. Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure) FRIEND TO FRIEND CPT CODES 2015 2016 CPT CODE SERVICE DESCRIPTION FEE EFFECTIVE G0101 Screening pelvic examination $36.69 01 Jan 16 G0202 Mammography, screening, digital, bilateral (2 view film study of

More information

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors L. Stewart Massad, MD, Mark H. Einstein, MD, Warner K. Huh, MD, Hormuzd A. Katki,

More information

Biomedical Engineering for Global Health. Lecture Thirteen

Biomedical Engineering for Global Health. Lecture Thirteen Biomedical Engineering for Global Health Lecture Thirteen Outline The burden of cancer How does cancer develop? Why is early detection so important? Strategies for early detection Example cancers/technologies

More information

P ROGRAMMATIC G UIDELINES FOR S CREENING FOR C ANCER OF THE C ERVIX I N C ANADA

P ROGRAMMATIC G UIDELINES FOR S CREENING FOR C ANCER OF THE C ERVIX I N C ANADA P ROGRAMMATIC G UIDELINES FOR S CREENING FOR C ANCER OF THE C ERVIX I N C ANADA CANADIAN SOCIETY OF CYTOLOGY SOCIÉTÉ CANADIENNE DE CYTOLOGIE The Society of Gynecologic Oncologists of Canada La société

More information

Colposcopic Management of Abnormal Cervical Cytology and Histology

Colposcopic Management of Abnormal Cervical Cytology and Histology No. 284, December 2012 Colposcopic Management of Abnormal Cervical Cytology and Histology This clinical practice guideline has been prepared by the Executive Council of the Society of Canadian Colposcopists

More information

Testing for HPV as an Objective Measure for Quality Assurance in Gynecologic Cytology

Testing for HPV as an Objective Measure for Quality Assurance in Gynecologic Cytology 67 Testing for HPV as an Objective Measure for Quality Assurance in Gynecologic Cytology Positive Rates in Equivocal and Abnormal Specimens and Comparison With the ASCUS to SIL Ratio Vincent Ko, MD Shabin

More information

Pre test Question 2. Emily D. Babcock, DHSc, PA C, DFAAPA CAPA Annual Conference Palm Springs, California October 4, 2013

Pre test Question 2. Emily D. Babcock, DHSc, PA C, DFAAPA CAPA Annual Conference Palm Springs, California October 4, 2013 Emily D. Babcock, DHSc, PA C, DFAAPA CAPA Annual Conference Palm Springs, California October 4, 2013 Objectives After completion of this presentation, the participant will be able to: Explain the current

More information

Cytopathology Case Presentation #8

Cytopathology Case Presentation #8 Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents

More information

Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older

Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older When to get tested and how to make sense of your test results If you are 30 years or older and your Pap test is normal

More information

National Guidelines for Prevention and Management of Cervical, Breast and Prostate Cancers 1

National Guidelines for Prevention and Management of Cervical, Breast and Prostate Cancers 1 National Guidelines for Prevention and Management of Cervical, Breast and Prostate Cancers 1 ACKNOWLEDGEMENTS Extensive consultations among various stakeholders marked the development process of these

More information

An abnormal Pap smear - what does it mean?

An abnormal Pap smear - what does it mean? An abnormal Pap smear - what does it mean? It is natural to feel worried if you have just found out that your Pap smear result is not normal (abnormal). Around 1 in 10 Pap smears will show changes in the

More information

Prepublication Requirements

Prepublication Requirements Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals

More information

Office Visits. Breast

Office Visits. Breast Early Detection Works Reimbursement Fee Schedule Effective for services on or after July 1, 2015 Program guidelines require that be the payor of last resort. Program funds cannot be used to supplement

More information

Building Awareness of Cervical Cancer

Building Awareness of Cervical Cancer Building Awareness of Cervical Cancer Guest Expert: Peter, MD John Slade Ely Professor of Obstetrics, Gynecology & Reproductive Sciences www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center

More information

Cervical Cancer Screening

Cervical Cancer Screening TOC NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Cervical Cancer Screening Version 2.2012 NCCN.g Continue Version 2.2012, 05/02/12 National Comprehensive Cancer Netwk, Inc. 2012, All

More information

Abigail R. Proffer, M.D. October 4, 2013

Abigail R. Proffer, M.D. October 4, 2013 Abigail R. Proffer, M.D. October 4, 2013 Topics Human Papillomavirus (HPV) Vaccines Pap smears Colposcopy Contraception Polycystic Ovary Syndrome (PCOS) Can I get pregnant? Miscarriage Abnormal Uterine

More information

MBS items (10994, 10995) for Pap smears and Preventive Checks taken by a Practice Nurse on behalf of a GP

MBS items (10994, 10995) for Pap smears and Preventive Checks taken by a Practice Nurse on behalf of a GP MBS items (10994, 10995) for Pap smears and Preventive Checks taken by a Practice Nurse on behalf of a GP Medicare item numbers 10994 and 10995 apply to Pap smears and preventive checks provided by a practice

More information

Further investigations, treatments and new technologies

Further investigations, treatments and new technologies Promoting Cervical Screening Information for Health Professionals Further investigations, treatments and new technologies Population Health Queensland Cancer Screening Services Branch Queensland Cervical

More information

Routine Vaginal Cuff Smear Testing in Post Hysterectomy Patients With Benign Uterine Conditions: When Is It Indicated?

Routine Vaginal Cuff Smear Testing in Post Hysterectomy Patients With Benign Uterine Conditions: When Is It Indicated? ORIGINAL ARTICLES Routine Vaginal Cuff Smear Testing in Post Hysterectomy Patients With Benign Uterine Conditions: When Is It Indicated? Andrea Videleftky, MD, Nonnan GrossI, MD, Maxine Denniston, MSPH,

More information

Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com

Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com News Release FOR IMMEDIATE RELEASE Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com Merck's HPV Vaccine, GARDASIL 9, now available

More information

CERVICAL CANCER What every woman should know What is a cervix?

CERVICAL CANCER What every woman should know What is a cervix? CERVICAL CANCER What every woman should know What is a cervix? The cervix is the entrance to the womb from the vagina. It is the narrow, lower part of the uterus that is the passageway connecting the uterus

More information

SITUATIONAL ANALYSIS OF CERVICAL CANCER PREVENTION AND CONTROL IN THE CARIBBEAN

SITUATIONAL ANALYSIS OF CERVICAL CANCER PREVENTION AND CONTROL IN THE CARIBBEAN SITUATIONAL ANALYSIS OF CERVICAL CANCER PREVENTION AND CONTROL IN THE CARIBBEAN Results from a 2013 assessment of country policies and services for HPV vaccination, cervical cancer screening, diagnosis

More information

Human Papilloma Virus (HPV)

Human Papilloma Virus (HPV) Human Papilloma Virus (HPV) A Sexually Transmitted Disease (STD) which can lead to Cervical, Penile and Anal Cancer What Adolescents Need to Know! Most people have heard of HIV/AIDS; however, most people

More information

Cancer Screening. Robert L. Robinson, MD, MS. Ambulatory Conference SIU School of Medicine Department of Internal Medicine.

Cancer Screening. Robert L. Robinson, MD, MS. Ambulatory Conference SIU School of Medicine Department of Internal Medicine. Cancer Screening Robert L. Robinson, MD, MS Ambulatory Conference SIU School of Medicine Department of Internal Medicine March 13, 2003 Why screen for cancer? Early diagnosis often has a favorable prognosis

More information

Vaccination and Screening for the Prevention of Cervical Cancer: Health Effects and Cost-effectiveness

Vaccination and Screening for the Prevention of Cervical Cancer: Health Effects and Cost-effectiveness Vaccination and Screening for the Prevention of Cervical Cancer: Health Effects and Cost-effectiveness Vaccinatie en screening voor de preventie van baarmoederhalskanker: Gezondheidseffecten en kosteneffectiviteit

More information

Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group

Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group Screening for Cancer in Light of New Guidelines and Controversies Christopher Celio, MD St. Jude Heritage Medical Group Screening Tests The 2 major objectives of a good screening program are: (1) detection

More information

What is HPV? Low-risk HPV types. High-risk HPV types

What is HPV? Low-risk HPV types. High-risk HPV types HPV and Cancer What is HPV? HPV is short for human papilloma (PAP-uh-LO-muh) virus. HPVs are a large group of related viruses. Each HPV virus in the group is given a number, which is called an HPV type.

More information

Immunization Healthcare Branch. Human Papillomavirus Vaccination Program Questions and Answers. Prepared by

Immunization Healthcare Branch. Human Papillomavirus Vaccination Program Questions and Answers. Prepared by Immunization Healthcare Branch Human Papillomavirus Vaccination Program Questions and Answers Prepared by Immunization Healthcare Branch (IHB), Defense Health Agency Last Updated: 02 Jan 14 www.vaccines.mil

More information

HPV testing in the follow-up of women post colposcopy treatment

HPV testing in the follow-up of women post colposcopy treatment HPV testing in the follow-up of women post colposcopy treatment Contents Background 2 Treatment of CIN and risk of recurrence 2 The natural history of HPV infections 2 HPV testing for women following

More information

NHS Cervical Screening Programme Achievable standards, Benchmarks for reporting, and Criteria for evaluating cervical cytopathology

NHS Cervical Screening Programme Achievable standards, Benchmarks for reporting, and Criteria for evaluating cervical cytopathology NHS Cervical Screening Programme Achievable standards, Benchmarks for reporting, and Criteria for evaluating cervical cytopathology third edition including revised performance indicators NHSCSP PubliCatioN

More information

4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED

4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS What is human papillomavirus (HPV)? HPV is the most common sexually transmitted infection. There are

More information

HPV OncoTect E6, E7 mrna Kit A highly specific molecular test for early detection of cervical cancer

HPV OncoTect E6, E7 mrna Kit A highly specific molecular test for early detection of cervical cancer Revolutionizing healthcare one cell at a time HPV OncoTect E6, E7 mrna Kit A highly specific molecular test for early detection of cervical cancer Numerous studies confirm that the presence of HR HPV DNA

More information

Appendix 1. HPVTest of Cure Management

Appendix 1. HPVTest of Cure Management Appendix 1. HPVTest of Cure Management 6 months post treatment cervical smear and HPV test 1. Smear negative or squamous. HPV negative 2. Smear negative, squamous, glandular or unsatisfactory. HPV positive

More information

TAKING SAMPLES FOR CERVICAL SCREENING. A Resource Pack for Trainers

TAKING SAMPLES FOR CERVICAL SCREENING. A Resource Pack for Trainers TAKING SAMPLES FOR CERVICAL SCREENING A Resource Pack for Trainers NHSCSP Publication No 23 April 2006 Published by: NHS Cancer Screening Programmes Fulwood House Old Fulwood Road Sheffield S10 3TH Tel:

More information

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30

More information

Cervical cancer is the second most common cancer among South African women

Cervical cancer is the second most common cancer among South African women Cervical cancer is the second most common cancer among South African women *SA Statistics as per National Cancer Registry (NCR) 2007 What is cervical cancer? Cervical cancer is a type of cancer that occurs

More information

The Role of the Pap Smear Diagnosis: Atypical Glandular Cells (AGC)

The Role of the Pap Smear Diagnosis: Atypical Glandular Cells (AGC) 15 The Role of the Pap Smear Diagnosis: Atypical Glandular Cells (AGC) Chiung-Ru Lai 1,2, Chih-Yi Hsu 1,2 and Anna Fen-Yau Li 1,2 1 Department of Pathology and Laboratory Medicine, Taipei Veterans General

More information

Procedure Code(s): n/a This counseling service is included in a preventive care wellness examination or focused E&M visit.

Procedure Code(s): n/a This counseling service is included in a preventive care wellness examination or focused E&M visit. Coding Summary for Providers NOTE THE FOLLOWING: The purpose of this document is to provide a quick reference of the applicable codes for UnitedHealthcare plans that cover preventive care services in accordance

More information

WELCOME TO COLLEGE HEIGHTS OBGYN ASSOCIATES

WELCOME TO COLLEGE HEIGHTS OBGYN ASSOCIATES WELCOME TO COLLEGE HEIGHTS OBGYN ASSOCIATES We are pleased you have selected College Heights OBGYN Associates for your obstetrical / gynecological care. Meeting a new medical provider can cause anxiety

More information

HUMAN PAPILLOMAVIRUS (HPV) TESTING

HUMAN PAPILLOMAVIRUS (HPV) TESTING MEDICAL POLICY HUMAN PAPILLOMAVIRUS (HPV) TESTING Policy Number: CDP - 041 Effective Date: October 1, 2014 Table of Contents Page BACKGROUND 1 POLICY 3 REFERENCES 5 POLICY HISTORY/REVISION HISTORY 7 INSTRUCTIONS

More information

CERVICAL CHANGES UNDERSTANDING A HEALTH GUIDE FOR WOMEN. family EDUCATION PATIENT. National Institutes of Health National Cancer Institute

CERVICAL CHANGES UNDERSTANDING A HEALTH GUIDE FOR WOMEN. family EDUCATION PATIENT. National Institutes of Health National Cancer Institute UNDERSTANDING CERVICAL CHANGES A HEALTH GUIDE FOR WOMEN PATIENT & family EDUCATION U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute A Pap Test Showed

More information

Abnormal Uterine Bleeding FAQ Sheet

Abnormal Uterine Bleeding FAQ Sheet Abnormal Uterine Bleeding FAQ Sheet What is abnormal uterine bleeding? Under normal circumstances, a woman's uterus sheds a limited amount of blood during each menstrual period. Bleeding that occurs between

More information

CYTOLOGY. Non-Gynecological Specimens (refer to the Cytology Specimen Collection Guidelines for a quick reference).

CYTOLOGY. Non-Gynecological Specimens (refer to the Cytology Specimen Collection Guidelines for a quick reference). CYTOLOGY Non-Gynecological Specimens (refer to the Cytology Specimen Collection Guidelines for a quick reference). A. General Considerations of Specimens 1. Specimens should be as fresh as possible. 2.

More information

Invasive Cervical Cancer. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology

Invasive Cervical Cancer. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Invasive Cervical Cancer Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer Etiology Human Papilloma Virus (HPV): Detected in 99.7% of cervical cancers Cancer

More information

What is cervical cancer?

What is cervical cancer? What is cervical cancer? Cervical cancer is a term used for a tumour that starts in the cervix where the uterus (womb) meets the vagina (birth canal). The cells of the cervix don t suddenly turn into cancer;

More information

INFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM

INFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM INFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM Inflammation is a response of a tissue to injury, often caused by invading microorganisms. The suffix which indicates inflammation is "-itis" (the

More information

CERVICAL CANCER SCREENING

CERVICAL CANCER SCREENING CERVICAL CANCER SCREENING APPLICATIONS OBJECTIVE Purpose of Measure: ELIGIBLE POPULATION Which members are included? STANDARD OF CARE What screening should be done? NCQA ACCEPTED CODES DOCUMENTATION REQUIREMENTS

More information

Ten Good Reasons to Be Concerned about the Human Papillomavirus (HPV) Vaccination Campaign

Ten Good Reasons to Be Concerned about the Human Papillomavirus (HPV) Vaccination Campaign Ten Good Reasons to Be Concerned about the Human Papillomavirus (HPV) Vaccination Campaign This document is a translation and adaption of an information brochure prepared by the Federation du Québec pour

More information

Preventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64

Preventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64 Preventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64 1. BMI - Documented in patients medical record on an annual basis. Screen for obesity and offer intensive counseling and behavioral

More information

Preventing Cervical Cancer with Gardasil Jana Ogden RN, MSN, MBA-HCA, IHCC Nursing Faculty. Upon Completion of the Lesson the student will be able to:

Preventing Cervical Cancer with Gardasil Jana Ogden RN, MSN, MBA-HCA, IHCC Nursing Faculty. Upon Completion of the Lesson the student will be able to: Preventing Cervical Cancer with Gardasil Jana Ogden RN, MSN, MBA-HCA, IHCC Nursing Faculty Upon Completion of the Lesson the student will be able to: Review statistics related to cervical cancer and HPV

More information

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Kerry C. Councilman, MD Assistant Professor University of Colorado Denver Goals: BRAF Mutation

More information

Carcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in

Carcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition, 2001 Vagina Jeffrey L. Stern, MD Carcinoma of the vagina is

More information

WHO GUIDANCE NOTE. Comprehensive cervical cancer prevention and control: a healthier future for girls and women

WHO GUIDANCE NOTE. Comprehensive cervical cancer prevention and control: a healthier future for girls and women WHO GUIDANCE NOTE Comprehensive cervical cancer prevention and control: a healthier future for girls and women WHO Library Cataloguing-in-Publication Data WHO guidance note: comprehensive cervical cancer

More information

Introduction to Gynecologic Oncology

Introduction to Gynecologic Oncology Objectives Cervical Dysplasia and Cancer Introduction to Gynecologic Oncology Department of Obstetrics and Gynecology University of Western Ontario Discuss the incidence and risk factors for cervical dysplasia

More information

This information is current as of September 20, 2006

This information is current as of September 20, 2006 American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer Debbie Saslow, Carolyn D. Runowicz, Diane Solomon, Anna-Barbara Moscicki, Robert A. Smith, Harmon J. Eyre and

More information